PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsPrp
Prp
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
1022 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
OsteoarthritisD010003EFO_0002506M15-M192539191880162
Knee osteoarthritisD020370EFO_0004616M172033161363128
Diabetic retinopathyD003930EFO_0003770—7181393472
Retinal diseasesD012164HP_0000479H35.96151283063
TendinopathyD052256EFO_1001434M77.936282240
UlcerD014456MPATH_579—95322338
DiphtheriaD004165EFO_0005549A36—3292135
SyndromeD013577——64531935
AlopeciaD000505HP_0002293L6465—41932
Rotator cuff injuriesD000070636—M75.154231831
Show 69 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hepatitis bD006509——1224—229
HepatitisD006505HP_0012115K75.9—123—226
AtrophyD001284——441—1523
Primary ovarian insufficiencyD016649EFO_0004266E28.3454—816
Erectile dysfunctionD007172EFO_0004234F52.21673—516
Premature menopauseD008594HP_0008209E28.31442—713
Female infertilityD007247EFO_0008560N97165—310
Hip osteoarthritisD015207EFO_1000786M16111—69
Healthy volunteers/patients———312—39
PainD010146EFO_0003843R52——2—68
Show 75 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.911——910
Diabetes mellitusD003920HP_0000819E08-E1332——59
CicatrixD002921HP_0100699L90.522——69
IschemiaD007511EFO_0000556—53——27
InflammationD007249MP_0001845—14——37
GynatresiaD006175EFO_1001335——3——36
Pathologic neovascularizationD009389——33——15
Joint diseasesD007592HP_0003040M12.912——25
Lichen sclerosus et atrophicusD018459—L90.012——35
Type 2 diabetes mellitusD003924EFO_0001360E1121——25
Show 49 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HeadacheD006261HP_0002315R512———1012
Migraine disordersD008881EFO_0003821G431———910
BursitisD002062EFO_1000941M71.93———69
NeuralgiaD009437EFO_0009430—2———24
RecurrenceD012008——1———34
Atrophic vaginitisD059268EFO_1001271—2———24
OsteonecrosisD010020EFO_0004259M872———13
Somatoform disordersD013001—F451———23
Wound infectionD014946——1———12
VaginitisD014627EFO_0005757N762————2
Show 38 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Migraine without auraD020326EFO_0005296G43.0————66
Lung diseasesD008171HP_0002088J98.4————66
Pilonidal sinusD010864HP_0010769L05————55
VitiligoD014820EFO_0004208L80————55
Skin ulcerD012883HP_0200042L98.4————44
Tissue adhesionsD000267——————44
Hemophilia aD006467EFO_0007267D66————33
Olfaction disordersD000857HP_0000458R43.0————33
Rheumatoid arthritisD001172EFO_0000685M06.9————33
Cartilage fracturesD050724——————33
Show 159 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification—
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use